Podiatrists in Signal Mountain, TN Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Foot Essentials Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 635 Alexian Way, Signal Mountain, TN 37377 Phone: 309-826-3774

Robert T Spalding Jr Dpm Area Podiatry Centers Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 Taft Hwy, Signal Mountain, TN 37377 Phone: 423-756-3668    Fax: 423-886-1142

Rachna Gupta, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 635 Alexian Way, Signal Mountain, TN 37377 Phone: 423-886-0338

Dr. Robert Tucker Spalding Jr., DPM Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Taft Hwy, Signal Mountain, TN 37377 Phone: 423-756-3668    Fax: 423-886-1142

News Archive

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Ken Kewley woke up Tuesday without health insurance for the first time in nearly nine years. So did most of the 41,467 other Pennsylvanians who had been covered by adultBasic, a state-subsidized insurance program for the working poor that Gov. Tom Corbett shut down on Monday in one of the largest disenrollments in recent memory.

DLnano-vaccines may be a promising strategy for cancer immunotherapy

Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.

Strategic alliances between firms yield more patents, innovation

Larger numbers of patents and more perceptible innovation are the outcomes of certain well-designed strategic alliances between firms, according to the Management Insights feature in the July special issue of Management Science on Complex Systems.

Selten Pharma's SPI-026 granted FDA Orphan Drug Designation for treatment of PAH

Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).

Read more Medical News

› Verified 2 days ago